Nylim GBL Ety R&D LDR ETF-UiWRNDETF
13F holders, Q4 2025 (December 31)1holders −2
0new positions
2sold out
$37.07avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holder was New York Life Investment Management LLC ($7.0M).
- Company
- Nylim GBL Ety R&D LDR ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q4 2025)
- CUSIP
- 45409B255
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $672K |
All 13F filers, Q3 2025 → Q4 2025: 18,644 shares sold, net −18,644 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $7.0M |
"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.